ADMA Biologics Inc vs C.H. Robinson Worldwide, Inc. — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while C.H. Robinson Worldwide, Inc. trades at $145.4 (market cap $16.96B). The key difference: C.H. Robinson Worldwide, Inc. is far larger — about 7.6× ADMA Biologics Inc's market cap, and C.H. Robinson Worldwide, Inc. pays a 1.74% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | CHRW | |
|---|---|---|
Market Cap | $2.22B | $16.96B |
Sector | Health | Industrials |
52-Week High | $20.38 | $209.42 |
52-Week Low | $7.60 | $118.77 |
Enterprise Value | $2.29B | $18.78B |
Dividend Yield | — | 1.74% |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
Read more on CHRW →